Molecular trans-dural efflux to skull bone marrow in humans with CSF disorders

  • Geir Ringstad
    Department of Radiology, Oslo University Hospital-Rikshospitalet, Pb 4950 Nydalen, N-0424 Oslo, Norway
  • Per Kristian Eide
    Department of Neurosurgery, Oslo University Hospital-Rikshospitalet, Pb 4950 Nydalen, N-0424 Oslo, Norway

説明

<jats:title>Abstract</jats:title> <jats:p>Dural sinuses were recently identified as a hub for peripheral immune surveillance of brain-derived antigens cleared through CSF. However, animal studies have also indicated that substances and cells may enter the intracranial compartment directly from bone marrow.</jats:p> <jats:p>We used MRI and a CSF tracer to investigate in vivo whether intracranial molecules can move via dura to skull bone marrow in patients with suspicion of CSF disorders. Tracer enrichment in CSF, dural regions and within skull bone marrow was assessed up to 48 h after intrathecal administration of gadobutrol (0.5 ml, 1 mmol/ml) in 53 patients. In participants diagnosed with disease, tracer enrichment within diploe of skull bone marrow was demonstrated nearby the parasagittal dura, nearby extensions of parasagittal dura into diploe, and in diploe of skull bone remote from the dura extensions.</jats:p> <jats:p>This crossing of meningeal and skull barriers suggests that bone marrow may contribute in brain immune surveillance also in humans.</jats:p>

収録刊行物

  • Brain

    Brain 145 (4), 1464-1472, 2021-11-25

    Oxford University Press (OUP)

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ